• FDA Rejects Romosozumab for Osteoporosis, Wants More Data

    4 monthes ago - By Medscape

    The FDA has issued a complete response letter for romosozumab; companies will have to submit more data from trials with the osteoporosis agent.
    Medscape Medical Ethics
    Read more ...